☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
circle pharma
Circle Pharma Reports the First Patient Dosing with CID-078 Under P-I Study for Advanced Solid Tumors
October 15, 2024
Circle Pharma Features Preclinical Results of CID-078 at the WCLC 2024
September 9, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.
